Abstract:Crouzon syndrome, caused by FGFR2 mutations, leads to premature cranial suture fusion and abnormal head shapes. This study used FGFR2C342Y mice to examine the mutation's effect on cranial bone microarchitecture during postnatal development. High‐resolution imaging of frontal and parietal bones in mutant and wild‐type mice revealed significant differences in bone volume fraction, canal and lacunar morphometry, especially in frontal bones. Mutants had larger, less dense lacunae around postnatal days 7–14. These findings improve understanding of Crouzon syndrome and aid in enhancing surgical outcomes. Crouzon syndrome is a congenital craniofacial disorder caused by mutations in the Fibroblast Growth Factor Receptor 2 (FGFR2). It is characterized by the premature fusion of cranial sutures, leading to a brachycephalic head shape, and midfacial hypoplasia. The aim of this study was to investigate the effect of the FGFR2 mutation on the microarchitecture of cranial bones at different stages of postnatal skull development, using the FGFR2C342Y mouse model. Apart from craniosynostosis, this model shows cranial bone abnormalities. High‐resolution synchrotron microtomography images of the frontal and parietal bone were acquired for both FGFR2C342Y/+ (Crouzon, heterozygous mutant) and FGFR2+/+ (control, wild‐type) mice at five ages (postnatal days 1, 3, 7, 14 and 21, n = 6 each). Morphometric measurements were determined for cortical bone porosity: osteocyte lacunae and canals. General linear model to assess the effect of age, anatomical location and genotype was carried out for each morphometric measurement. Histological analysis was performed to validate the findings. In both groups (Crouzon and wild‐type), statistical difference in bone volume fraction, average canal volume, lacunar number density, lacunar volume density and canal volume density was found at most age points, with the frontal bone generally showing higher porosity and fewer lacunae. Frontal bone showed differences between the Crouzon and wild‐type groups in terms of lacunar morphometry (average lacunar volume, lacunar number density and lacunar volume density) with larger, less dense lacunae around the postnatal age of P7–P14. Histological analysis of bone showed marked differences in frontal bone only. These findings provide a better understanding of the pathogenesis of Crouzon syndrome and will contribute to computational models that predict postoperative changes with the aim to improve surgical outcome.

Craniosynostosis‐associated variants in the IL‐11R complex: new insights and questions

The structure of the IL‐11 signalling complex provides insight into receptor variants associated with craniosynostosis

Molecular characterization of the craniosynostosis‐associated interleukin‐11 receptor variants p.T306_S308dup and p.E364_V368del

The interleukin-11 receptor variant p.W307R results in craniosynostosis in humans

Mutations in the Interleukin Receptor IL11RA Cause Autosomal Recessive Crouzon-like Craniosynostosis

Dosage‐dependent effects of FGFR2W290R mutation on craniofacial shape and cellular dynamics of the basicranial synchondroses

De novo variants implicate chromatin modification, transcriptional regulation, and retinoic acid signaling in syndromic craniosynostosis

Impairment of Interleukin 11 Signaling As a Novel Pathomechanism Underlying Crouzon-like Syndrome and Pansynostosis

Apical expansion of calvarial osteoblasts and suture patency is dependent on fibronectin cues

Osteogenesis imperfecta type 10 and the cellular scaffolds underlying common immunological diseases

Structures of the interleukin 11 signalling complex reveal gp130 dynamics and the inhibitory mechanism of a cytokine variant

Signaling Mechanisms Underlying Genetic Pathophysiology Of Craniosynostosis

Facial skeleton dysmorphology in syndromic craniosynostosis: differences between FGFR2 and no-FGFR2-related syndromes and relationship with skull base and facial sutural patterns

A biallelic mutation in IL6ST encoding the GP130 co-receptor causes immunodeficiency and craniosynostosis

196 Multi-omic Convergence of Human Craniosynostosis Genes Within a Developmental Bone-Dura-Brain Nexus

Structural insights into IL-11-mediated signalling and human IL6ST variant-associated immunodeficiency

The Impact of Genetic Variability of TGF-Beta Signaling Biomarkers in Major Craniofacial Syndromes

Dysregulation of the HOTAIR-miR-152-CAMKIIα Axis in Craniosynostosis Results in Impaired Osteoclast Differentiation

Cranial bone microarchitecture in a mouse model for syndromic craniosynostosis

Skeletal stem and progenitor cells maintain cranial suture patency and prevent craniosynostosis

The clinical manifestations, molecular mechanisms and treatment of craniosynostosis